JP2010538282A5 - - Google Patents

Download PDF

Info

Publication number
JP2010538282A5
JP2010538282A5 JP2010523316A JP2010523316A JP2010538282A5 JP 2010538282 A5 JP2010538282 A5 JP 2010538282A5 JP 2010523316 A JP2010523316 A JP 2010523316A JP 2010523316 A JP2010523316 A JP 2010523316A JP 2010538282 A5 JP2010538282 A5 JP 2010538282A5
Authority
JP
Japan
Prior art keywords
reg
psp
concentration
antibody
onset
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010523316A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010538282A (ja
JP5048838B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/007158 external-priority patent/WO2009030456A1/en
Publication of JP2010538282A publication Critical patent/JP2010538282A/ja
Publication of JP2010538282A5 publication Critical patent/JP2010538282A5/ja
Application granted granted Critical
Publication of JP5048838B2 publication Critical patent/JP5048838B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010523316A 2007-09-07 2008-09-02 ヒト敗血症を測定する方法 Active JP5048838B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07017539.3 2007-09-07
EP07017539 2007-09-07
PCT/EP2008/007158 WO2009030456A1 (en) 2007-09-07 2008-09-02 Method for assaying sepsis in humans

Publications (3)

Publication Number Publication Date
JP2010538282A JP2010538282A (ja) 2010-12-09
JP2010538282A5 true JP2010538282A5 (enExample) 2011-10-20
JP5048838B2 JP5048838B2 (ja) 2012-10-17

Family

ID=40040164

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010523316A Active JP5048838B2 (ja) 2007-09-07 2008-09-02 ヒト敗血症を測定する方法

Country Status (13)

Country Link
US (2) US8435755B2 (enExample)
EP (1) EP2185937B2 (enExample)
JP (1) JP5048838B2 (enExample)
CN (1) CN101796418B (enExample)
AT (1) ATE514950T1 (enExample)
AU (1) AU2008295046B2 (enExample)
CA (1) CA2696319C (enExample)
DK (1) DK2185937T4 (enExample)
ES (1) ES2368877T5 (enExample)
NZ (1) NZ583474A (enExample)
PL (1) PL2185937T5 (enExample)
PT (1) PT2185937E (enExample)
WO (1) WO2009030456A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2577316B1 (en) 2010-05-31 2017-02-08 University Hospital of Basel Method for assaying lower respiratory tract infection or inflammation
SI2612152T1 (sl) 2010-08-31 2020-10-30 Otto-Von-Guericke-Universitaet Magdeburg Postopek za diagnozo infektivnega peritonitisa in napoved resnosti in izida le-tega pri ljudeh
US20130004968A1 (en) * 2010-09-22 2013-01-03 Robert Webber Sepsis blood biomarker system
WO2014009480A1 (en) 2012-07-12 2014-01-16 Universität Zürich Method for assaying sepsis and outcome in humans by detection of psp/reg
WO2014068018A1 (en) * 2012-10-30 2014-05-08 Abbott Gmbh & Co.Kg Methods of prognosis and diagnosis of sepsis
WO2014117165A1 (en) * 2013-01-28 2014-07-31 Vanderbilt University Method for differentiating sepsis and systemic inflammatory response syndrome (sirs)
EP2813852A3 (en) 2013-06-11 2015-03-25 University Of Zurich Method for detecting the development of an infection in humans
CN106367488A (zh) * 2016-08-29 2017-02-01 北京泱深生物信息技术有限公司 Letmd1在脓毒症诊断中的应用
EP3438668A1 (en) 2017-08-04 2019-02-06 B.R.A.H.M.S GmbH Diagnosis and risk stratification of fungal infections
US11327082B2 (en) 2017-09-13 2022-05-10 B.R.A.H.M.S Gmbh Proadrenomedullin as a marker for abnormal platelet levels
CA3075440A1 (en) 2017-09-13 2019-03-21 B.R.A.H.M.S Gmbh Pro-adm as a therapy monitoring marker for critcally ill patients
EP3502706A1 (en) 2017-12-20 2019-06-26 B.R.A.H.M.S GmbH Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
CN108181472B (zh) * 2018-03-05 2020-07-21 吉林大学 昆虫细胞表达psp为校准品的检测psp试剂盒
EP3578989A1 (en) 2018-06-06 2019-12-11 B.R.A.H.M.S GmbH Pro-adm for prognosis of trauma-related complications in polytrauma patients
FR3087338B1 (fr) 2018-10-22 2020-10-09 Amadeite Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
AU2020475845A1 (en) * 2020-11-03 2023-06-08 Abionic Sa Method for assessing the severity of sars
CN117242350A (zh) * 2021-04-30 2023-12-15 豪夫迈·罗氏有限公司 用于脓毒症的早期检测的il6标志物组
CA3233713A1 (en) * 2021-11-25 2023-06-01 Nicolas Durand Method for the management of antibiotic administration

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0378924B1 (en) * 1988-12-21 1996-11-13 The General Hospital Corporation Detection of neurological disease or dysfunction
GB9613629D0 (en) 1996-06-28 1996-08-28 Univ Leeds Reg gene expression in cancer tissue
DE50104561D1 (de) * 2001-12-04 2004-12-23 Brahms Ag Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
ATE272215T1 (de) * 2001-12-04 2004-08-15 Brahms Ag Verfahren zur diagnose von sepsis unter bestimmung von ca 19-9
ATE293794T1 (de) 2001-12-04 2005-05-15 Brahms Ag Verfahren zur diagnose von sepsis unter bestimmung von ca 125
ATE272214T1 (de) * 2001-12-04 2004-08-15 Brahms Ag Verfahren zur diagnose von sepsis unter bestimmung von s100b
DE10228103A1 (de) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
JP2004194534A (ja) * 2002-12-17 2004-07-15 Sumitomo Pharmaceut Co Ltd 炎症性腸疾患疾患マーカーおよびその利用
DE602004015064D1 (de) 2003-01-06 2008-08-28 Wyeth Corp Zusammensetzungen und verfahren zur diagnose und behandlung von kolonkrebs
WO2004087874A2 (en) * 2003-03-28 2004-10-14 Nuvelo, Inc. Novel nucleic acids and polypeptides
US20070224638A1 (en) 2006-03-27 2007-09-27 Institut Pasteur Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
EP2577316B1 (en) * 2010-05-31 2017-02-08 University Hospital of Basel Method for assaying lower respiratory tract infection or inflammation

Similar Documents

Publication Publication Date Title
JP2010538282A5 (enExample)
Zhou et al. Sensitive sandwich ELISA based on a gold nanoparticle layer for cancer detection
Wu et al. Portable GMR handheld platform for the detection of influenza A virus
Sener et al. Rapid real-time detection of procalcitonin using a microcontact imprinted surface plasmon resonance biosensor
HRP20201840T1 (hr) Postupci za ocjenjivanje imunološkog odgovora na terapijsko sredstvo
JP2014508298A5 (enExample)
Kumbhat et al. Surface plasmon resonance biosensor for dopamine using D3 dopamine receptor as a biorecognition molecule
JP2015230280A5 (enExample)
JP2012509477A5 (enExample)
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
BR112014018831B1 (pt) Método de formação de um sensor para um ou mais analitos
Liu et al. Efficient molecular imprinting strategy for quantitative targeted proteomics of human transferrin receptor in depleted human serum
WO2008007242A3 (en) Increased specificity of analyte detection by measurement of bound and unbound labels
JP2013513113A5 (enExample)
JP2013072663A5 (enExample)
EP2583101A1 (en) Multi epitope assay
WO2006083367A3 (en) Immunoassay employing two-step internal calibration reaction
WO2014018278A3 (en) Multisignal reagents for labeling analytes
CN104614498A (zh) 食品中致病菌检测的巨磁阻抗效应生物传感器
CN103278621A (zh) 一种利用生物传感器与血糖仪检测转录因子的方法
CN110095592A (zh) 一种c反应蛋白单膜检测干片
Çam Derin et al. Comparison of six aptamer-aptamer pairs on rapid detection of SARS-CoV-2 by lateral flow assay
CN104849443B (zh) 基于pH计的酶联免疫吸附测定方法
Wei et al. Label-free detection of pepsinogen 1 and 2 by polyethylene coating Lamb microfluidic device
CN104360083B (zh) 一种定量检测类风湿因子、抗链球菌溶血素o、c反应蛋白的检测试剂盒